واکسن سرطان سرویکس به عنوان یک اولویت بهداشت عمومی در ایران

Title

Cervical Cancer Vaccine as a Priority of public health practices in Iran

English Abstract

Cervical cancer is the third most common cancer in women. In poor countries, it is the second cause of cancer death [1]. According to official report of World Health Organization, about 500,000 new cases of cervical cancer were recorded each year that more than half of them are leading to death. 80 percent of new cases are occurred in developing countries [2]. The mean age of suffered patients is 50-52 years but two picks of disease prevalence are 40-39 and 60-64 years. The origin of the cervical cancer is the human papillomavirus (HPV), and if it enters to the body, the cancer cells were appeared about 12 to 24 months later. HPV is a viral disease that directly involved mouth, throat and larynges, anus, cervix, and penis [3, 4]. Sex is the main cause of the transmission of the HPV. Women at any age are in danger. The HPV infection could easily transmitted, even with a single sexual contact via an asymptomatic carrier. Of all 10 women, 8 people are infected with HPV during their lifetime. This infection is also sawn in men. Most infections of HPV are self-limited [3]. If the virus persist for a long time, it can cause serious problems in the skin, especially the genital area. It often has not symptoms, so many people are not aware from it. [3]

Document Downloads